カテゴリー： QYResearch, 世界, 医療/バイオ

世界の脳卒中治療市場インサイト及び予測（静脈注射、経口剤、その他）

◆英語タイトル：Global Stroke Therapeutics Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09291 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：111 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、脳卒中治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脳卒中治療の世界市場のxxx％を占める「静脈注射」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「虚血性脳卒中」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
脳卒中治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの脳卒中治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

脳卒中治療のグローバル主要企業には、Abbott Laboratories、Cordis、Boston Scientific、Siemens、Genentech、Koninklijke Philips、Medtronic、GE Healthcare、Stryker、Merck、Zocere, Inc.、Acticor Biotech、DiaMedica Therapeutics、Lumosa Therapeutics、AXONIS Therapeutics , Inc.、NovaGo Therapeuticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

脳卒中治療市場は、種類と用途によって区分されます。世界の脳卒中治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
静脈注射、経口剤、その他

【用途別セグメント】
虚血性脳卒中、出血性脳卒中、一過性脳虚血発作

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 脳卒中治療製品概要
- 種類別市場（静脈注射、経口剤、その他）
- 用途別市場（虚血性脳卒中、出血性脳卒中、一過性脳虚血発作）
- 調査の目的
・エグゼクティブサマリー
- 世界の脳卒中治療販売量予測2017-2028
- 世界の脳卒中治療売上予測2017-2028
- 脳卒中治療の地域別販売量
- 脳卒中治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別脳卒中治療販売量
- 主要メーカー別脳卒中治療売上
- 主要メーカー別脳卒中治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（静脈注射、経口剤、その他）
- 脳卒中治療の種類別販売量
- 脳卒中治療の種類別売上
- 脳卒中治療の種類別価格
・用途別市場規模（虚血性脳卒中、出血性脳卒中、一過性脳虚血発作）
- 脳卒中治療の用途別販売量
- 脳卒中治療の用途別売上
- 脳卒中治療の用途別価格
・北米市場
- 北米の脳卒中治療市場規模（種類別、用途別）
- 主要国別の脳卒中治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの脳卒中治療市場規模（種類別、用途別）
- 主要国別の脳卒中治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の脳卒中治療市場規模（種類別、用途別）
- 主要国別の脳卒中治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の脳卒中治療市場規模（種類別、用途別）
- 主要国別の脳卒中治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの脳卒中治療市場規模（種類別、用途別）
- 主要国別の脳卒中治療市場規模（トルコ、サウジアラビア）
・企業情報
Abbott Laboratories、Cordis、Boston Scientific、Siemens、Genentech、Koninklijke Philips、Medtronic、GE Healthcare、Stryker、Merck、Zocere, Inc.、Acticor Biotech、DiaMedica Therapeutics、Lumosa Therapeutics、AXONIS Therapeutics , Inc.、NovaGo Therapeutics
・産業チェーン及び販売チャネル分析
- 脳卒中治療の産業チェーン分析
- 脳卒中治療の原材料
- 脳卒中治療の生産プロセス
- 脳卒中治療の販売及びマーケティング
- 脳卒中治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 脳卒中治療の産業動向
- 脳卒中治療のマーケットドライバー
- 脳卒中治療の課題
- 脳卒中治療の阻害要因
・主な調査結果

Market Analysis and Insights: Global Stroke Therapeutics Market
The global Stroke Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Intravenous Injection accounting for % of the Stroke Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Ischemic Stroke segment is altered to an % CAGR throughout this forecast period.
China Stroke Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Stroke Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Stroke Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stroke Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stroke Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stroke Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stroke Therapeutics market.
Global Stroke Therapeutics Scope and Market Size
Stroke Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Stroke Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Intravenous Injection
Oral
Others
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Company
Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
Merck
Zocere, Inc.
Acticor Biotech
DiaMedica Therapeutics
Lumosa Therapeutics
AXONIS Therapeutics , Inc.
NovaGo Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intravenous Injection
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Stroke Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ischemic Stroke
1.3.3 Hemorrhagic Stroke
1.3.4 Transient Ischemic Attack
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stroke Therapeutics Market Perspective (2017-2028)
2.2 Stroke Therapeutics Growth Trends by Region
2.2.1 Stroke Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Stroke Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Stroke Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Stroke Therapeutics Market Dynamics
2.3.1 Stroke Therapeutics Industry Trends
2.3.2 Stroke Therapeutics Market Drivers
2.3.3 Stroke Therapeutics Market Challenges
2.3.4 Stroke Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Therapeutics Players by Revenue
3.1.1 Global Top Stroke Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Stroke Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stroke Therapeutics Revenue
3.4 Global Stroke Therapeutics Market Concentration Ratio
3.4.1 Global Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Therapeutics Revenue in 2021
3.5 Stroke Therapeutics Key Players Head office and Area Served
3.6 Key Players Stroke Therapeutics Product Solution and Service
3.7 Date of Enter into Stroke Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Therapeutics Breakdown Data by Type
4.1 Global Stroke Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Stroke Therapeutics Forecasted Market Size by Type (2023-2028)
5 Stroke Therapeutics Breakdown Data by Application
5.1 Global Stroke Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Stroke Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Stroke Therapeutics Market Size (2017-2028)
6.2 North America Stroke Therapeutics Market Size by Type
6.2.1 North America Stroke Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Stroke Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Stroke Therapeutics Market Share by Type (2017-2028)
6.3 North America Stroke Therapeutics Market Size by Application
6.3.1 North America Stroke Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Stroke Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Stroke Therapeutics Market Share by Application (2017-2028)
6.4 North America Stroke Therapeutics Market Size by Country
6.4.1 North America Stroke Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Stroke Therapeutics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Stroke Therapeutics Market Size (2017-2028)
7.2 Europe Stroke Therapeutics Market Size by Type
7.2.1 Europe Stroke Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Stroke Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Stroke Therapeutics Market Share by Type (2017-2028)
7.3 Europe Stroke Therapeutics Market Size by Application
7.3.1 Europe Stroke Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Stroke Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Stroke Therapeutics Market Share by Application (2017-2028)
7.4 Europe Stroke Therapeutics Market Size by Country
7.4.1 Europe Stroke Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Stroke Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stroke Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Stroke Therapeutics Market Size by Type
8.2.1 Asia-Pacific Stroke Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Stroke Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Stroke Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Stroke Therapeutics Market Size by Application
8.3.1 Asia-Pacific Stroke Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Stroke Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Stroke Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Stroke Therapeutics Market Size by Region
8.4.1 Asia-Pacific Stroke Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Stroke Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stroke Therapeutics Market Size (2017-2028)
9.2 Latin America Stroke Therapeutics Market Size by Type
9.2.1 Latin America Stroke Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Stroke Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Stroke Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Stroke Therapeutics Market Size by Application
9.3.1 Latin America Stroke Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Stroke Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Stroke Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Stroke Therapeutics Market Size by Country
9.4.1 Latin America Stroke Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Stroke Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Stroke Therapeutics Market Size by Type
10.2.1 Middle East & Africa Stroke Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Stroke Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Stroke Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Stroke Therapeutics Market Size by Application
10.3.1 Middle East & Africa Stroke Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Stroke Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Stroke Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Stroke Therapeutics Market Size by Country
10.4.1 Middle East & Africa Stroke Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Stroke Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Stroke Therapeutics Introduction
11.1.4 Abbott Laboratories Revenue in Stroke Therapeutics Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Cordis
11.2.1 Cordis Company Details
11.2.2 Cordis Business Overview
11.2.3 Cordis Stroke Therapeutics Introduction
11.2.4 Cordis Revenue in Stroke Therapeutics Business (2017-2022)
11.2.5 Cordis Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Stroke Therapeutics Introduction
11.3.4 Boston Scientific Revenue in Stroke Therapeutics Business (2017-2022)
11.3.5 Boston Scientific Recent Developments
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Stroke Therapeutics Introduction
11.4.4 Siemens Revenue in Stroke Therapeutics Business (2017-2022)
11.4.5 Siemens Recent Developments
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Stroke Therapeutics Introduction
11.5.4 Genentech Revenue in Stroke Therapeutics Business (2017-2022)
11.5.5 Genentech Recent Developments
11.6 Koninklijke Philips
11.6.1 Koninklijke Philips Company Details
11.6.2 Koninklijke Philips Business Overview
11.6.3 Koninklijke Philips Stroke Therapeutics Introduction
11.6.4 Koninklijke Philips Revenue in Stroke Therapeutics Business (2017-2022)
11.6.5 Koninklijke Philips Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Stroke Therapeutics Introduction
11.7.4 Medtronic Revenue in Stroke Therapeutics Business (2017-2022)
11.7.5 Medtronic Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Stroke Therapeutics Introduction
11.8.4 GE Healthcare Revenue in Stroke Therapeutics Business (2017-2022)
11.8.5 GE Healthcare Recent Developments
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Stroke Therapeutics Introduction
11.9.4 Stryker Revenue in Stroke Therapeutics Business (2017-2022)
11.9.5 Stryker Recent Developments
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Stroke Therapeutics Introduction
11.10.4 Merck Revenue in Stroke Therapeutics Business (2017-2022)
11.10.5 Merck Recent Developments
11.11 Zocere, Inc.
11.11.1 Zocere, Inc. Company Details
11.11.2 Zocere, Inc. Business Overview
11.11.3 Zocere, Inc. Stroke Therapeutics Introduction
11.11.4 Zocere, Inc. Revenue in Stroke Therapeutics Business (2017-2022)
11.11.5 Zocere, Inc. Recent Developments
11.12 Acticor Biotech
11.12.1 Acticor Biotech Company Details
11.12.2 Acticor Biotech Business Overview
11.12.3 Acticor Biotech Stroke Therapeutics Introduction
11.12.4 Acticor Biotech Revenue in Stroke Therapeutics Business (2017-2022)
11.12.5 Acticor Biotech Recent Developments
11.13 DiaMedica Therapeutics
11.13.1 DiaMedica Therapeutics Company Details
11.13.2 DiaMedica Therapeutics Business Overview
11.13.3 DiaMedica Therapeutics Stroke Therapeutics Introduction
11.13.4 DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2017-2022)
11.13.5 DiaMedica Therapeutics Recent Developments
11.14 Lumosa Therapeutics
11.14.1 Lumosa Therapeutics Company Details
11.14.2 Lumosa Therapeutics Business Overview
11.14.3 Lumosa Therapeutics Stroke Therapeutics Introduction
11.14.4 Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2017-2022)
11.14.5 Lumosa Therapeutics Recent Developments
11.15 AXONIS Therapeutics , Inc.
11.15.1 AXONIS Therapeutics , Inc. Company Details
11.15.2 AXONIS Therapeutics , Inc. Business Overview
11.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Introduction
11.15.4 AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2017-2022)
11.15.5 AXONIS Therapeutics , Inc. Recent Developments
11.16 NovaGo Therapeutics
11.16.1 NovaGo Therapeutics Company Details
11.16.2 NovaGo Therapeutics Business Overview
11.16.3 NovaGo Therapeutics Stroke Therapeutics Introduction
11.16.4 NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2017-2022)
11.16.5 NovaGo Therapeutics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の脳卒中治療市場インサイト及び予測（静脈注射、経口剤、その他）(Global Stroke Therapeutics Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の脳卒中治療市場インサイト及び予測（静脈注射、経口剤、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp